Related Experiment Videos
Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients
Insights
Labetalol (L) and propranolol (P) were compared for treating essential hypertension. Labetalol showed slightly greater blood pressure reduction and uniquely attenuated exercise-induced blood pressure rise, possibly due to its alpha-blocking action.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Essential hypertension is a common condition requiring effective pharmacologic management.
- Beta-blockers are a cornerstone in hypertension treatment, but their effects on vascular resistance and exercise response vary.
- Labetalol possesses both beta- and alpha-adrenergic blocking properties, differentiating it from traditional beta-blockers like propranolol.
Purpose of the Study:
- To compare the efficacy and effects of labetalol and propranolol in patients with essential hypertension.
- To investigate the impact of these drugs on blood pressure response during isometric exercise.
- To assess changes in resting vascular resistance and basal vascular tone.
Main Methods:
- A double-blind, cross-over study involving eleven patients with essential hypertension.
- Patients received titrated doses of labetalol and propranolol for 5-8 weeks each.
- Blood pressure, vascular resistance, and response to isometric handgrip exercise were measured.
Main Results:
- Labetalol (mean daily dose 636 mg) was slightly more effective in lowering supine and standing blood pressure than propranolol (mean dose 276 mg).
- Labetalol attenuated the blood-pressure rise during near-maximal handgrip, an effect not typically seen with other beta-blockers.
- Resting vascular resistance and basal vascular tone were significantly lower with labetalol compared to propranolol.
Conclusions:
- Labetalol demonstrates superior blood pressure lowering and unique cardiovascular effects compared to propranolol in essential hypertension.
- The observed differences are likely attributable to labetalol's combined alpha- and beta-adrenergic blockade.
- Labetalol's ability to mitigate exercise-induced hypertension warrants further investigation.
Abstract:
Eleven patients with essential hypertension participated in a double-blind cross-over comparison of labetalol (L) and propranolol (P). Each drug was given for 5--8 weeks. The dose reducing the supine diastolic blood pressure when given b.d. to or below 90 mm Hg was titrated out. At the end of each period, isometric exercise (sustained handgrip) and calf plethysmography were performed. L (mean daily dose 636 mg) was slightly more effective in lowering supine and standing blood pressure than P (mean dose 276 mg). There was no significant difference between the drugs in their effect on the blood-pressure response to handgrip. However, compared with no treatment, L attenuated the blood-pressure rise at near-maximal handgrip; this has not been reported with other beta-blockers. Resting vascular resistance and basal vascular tone were significantly lower (20%, p less than 0.05) during treatment with labetalol than when the patients were taking propranolol. - The differences may be explained by the alpha-receptorblocking action of labetalol.